Genomic Valley Biotech Ltd
GVBL.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$97.41M
Close$
$-8.49
126.6% downside
Current Fair Value
126.6% downsideOvervalued by 126.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $97.41 Million |
|---|---|
| Enterprise Value | $97.41 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.09 |
| Beta | -0.16 |
| Outstanding Shares | 2,923,240 |
Return
| Return on Equity | 0.52% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 504.59 |
|---|---|
| PEG | -1239.39 |
| Price to Sales | - |
| Price to Book Ratio | 2.45 |
| Enterprise Value to Revenue | 45.2 |
| Enterprise Value to EBIT | 324.65 |
| Enterprise Value to Net Income | 480 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Genomic Valley Biotech Ltd
8 employees
CEO: Tejas Soni Genomic Valley Biotech Limited operates in horticulture business activities in India. The company involved in the commercial greenhouse/poly house cultivation of crops; commercial horticulture activities with aloe vera, tomato, bitter go...